Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study-Reference-Cited by-同舟云学术

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

Published:2017 Issue:1 Volume:20 Page:21426
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Boyd Anders,Bottero Julie,Miailhes Patrick,Lascoux-Combe Caroline,Rougier Hayette,Girard Pierre-Marie,Serfaty Lawrence,Lacombe Karine

Funder

ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)

Gilead Sciences

French HIV-HBV

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

SIDACTION

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference39 articles.

1. REVEAL-HBV Study Group;Chen;Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology.,2009

2. Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load;Gordon;Hepatology.,2013

3. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B;Kitrinos;Hepatology.,2014

4. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet.,2013

5. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy;Papatheodoridis;J Hepatol.,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV and liver disease;Treatment and Management of Tropical Liver Disease;2025

2. Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy;eBioMedicine;2024-04

3. Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients—A Cohort from the North-Eastern Part of Romania;Microorganisms;2023-11-30

4. HIV-HBV Coinfection—Current Challenges for Virologic Monitoring;Biomedicines;2023-04-28

5. HBV and HCV Coinfection in Patients Living with HIV;Klimik Dergisi/Klimik Journal;2023-03-21